tumsasedgars Anavex Existence Sciences Corp. (NASDAQ:AVXL), a neurology-focused biotech, misplaced ~16% on Monday Morning after the corporate introduced fiscal 2022 financials and issued a industry
tumsasedgars Anavex Existence Sciences Corp. (NASDAQ:AVXL), a neurology-focused biotech, misplaced ~16% on Monday Morning after the corporate introduced fiscal 2022 financials and issued a industry